Novel universal vaccine presenting system

The European patent WO2022218997, filed by Pascal Fender’s team (IBS/MEM), protects a universal vaccine platform. Entirely protein-derived and thermostable, it allows the spontaneous and irreversible display of complex antigens using a ’plug and display’ technology.
Preclinical studies have shown its efficacy in the field of emerging infectious diseases such as coronaviruses (Chevillard et al., Mol Ther 2022, https://doi.org/10.1016/j.ymthe.2022.02.011) and in oncology in the context of melanoma (Besson et al., Biomedicines 2022, https://doi.org/10.3390/biomedicines10112881 and Besson et al., Mol Ther Meth Clin Devpt 2022, https://doi.org/10.1016/j.omtm.2022.12.003).
This patent is the subject of both a maturation and start-up incubation programme by SATT Linksium.